Bengaluru, April 17 -- Medical technology company Medikabazaar's investors have filed an indemnity claim, or compensation, of Rs.279 crore against the company over allegations of financial misreporting last year.

"The Parent has received a communication from its Series C investors on an indemnity claim of INR 27,870 lakh ( Rs.279 crore) for the past period misreporting. The Parent has been legally advised that it has a reasonable case to not accept the claim," the consolidated FY23 financial statement of Boston Ivy Healthcare Solutions Pvt Ltd, the parent company of Medikabazaar, showed.

In July last year, Mint reported that Medikabazaar's founders Vivek Tiwari and Ketan Malkan may not beawarded the stock options due to them this year a...